The term “transnational” developed over the 20th century to describe cosmopolitan, multicultural societies that stem from migration; the concept of transnational feminist translation studies adds references to postcolonial feminisms to this term, offering new collaborative avenues of research and publication. This article reports on the challenges such collaborations pose, and how they have impacted an early attempt to produce an anthology of scholarly texts in the area of transnational feminist translation studies (Flotow and Farahzad, 2017). It develops a number of specific areas of difficulty: the “hegemony” of English in academic publishing and how this affects the circulation of feminist texts from beyond the Anglo-American Eurozone; the issue of power relations between editors and authors, cultures, and languages; questions of inclusion and exclusion, especially as different religious/cultural backgrounds affect scholarly discussion; and the importance of women’s/feminist diversity as well as the risks/benefits of a universalizing discourse. While the article is concerned with “challenges”, it ends with a call for more such collaborative transnational work to re-energize and promote the field of feminist translation studies worldwide.
Résumé
L'auteur d'ascendance turque Özdamar, dont le deuxième roman, écrit en allemand, s'intitule Das Leben ist eine Karawanserai (1992), a obtenu des prix littéraires allemands. Le lieu de l'action du roman, les personnages, les proverbes et les rites religieux et culturels sont turcs; il en est de même pour la structure des phrases, les jeux de mots et les images. Traduire de l'allemand a consisté à traduire une traduction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.